Skip to main content
Clinical Trials/ISRCTN96643197
ISRCTN96643197
Completed
未知

An observational study to assess & predict the in-patient course, risk of readmission and mortality for patients hospitalised for or with Heart Failure

Hull and East Yorkshire Hospitals NHS Trust0 sites1,145 target enrollmentApril 18, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Topic: Cardiovascular
Sponsor
Hull and East Yorkshire Hospitals NHS Trust
Enrollment
1145
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Registry
who.int
Start Date
April 18, 2013
End Date
December 31, 2017
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hull and East Yorkshire Hospitals NHS Trust

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria for the Risk Stratification Component:
  • 1\. Age \>18 years
  • 2\. In hospital
  • 3\. Usual residence is in the catchment region for Hull \& East Yorkshire Hospitals Trust (this enables efficient follow\-up)
  • 4\.1\. Treated with loop diuretics Or
  • 4\.2\.Clinical diagnosis of heart failure
  • 5\. Willing and able to provide informed consent
  • Additional Inclusion Criteria for the Monitoring Component of the Study:
  • Heart failure as a dominant diagnosis meaning that
  • 1\. There is objective evidence of cardiac dysfunction as evidenced by a least ONE of the following:

Exclusion Criteria

  • Unable to understand and comply with protocol or to give informed consent. There are no other exclusion criteria for the risk stratification study.
  • Additional Exclusion Criteria for the Monitoring Component of the Study:
  • The duration of admission is likely to be determined by the need for treatment other than for heart failure (for instance, patients with infective endocarditis, major stroke disability or major cognitive impairment will be excluded).

Outcomes

Primary Outcomes

Not specified

Similar Trials